'en:pralidoxime mesylate'
(id=6971285 ; fe=en:pralidoxime mesylate ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=1317 creation date=2017-06-25 touchdate=2026-04-18 03:08:26.000) ≈ 49 relations sortantes
- en:pralidoxime mesylate --
r_associated #0: 42 / 1 ->
en:vedaclidine
n1=en:pralidoxime mesylate | n2=en:vedaclidine | rel=r_associated | relid=0 | w=42
- en:pralidoxime mesylate --
r_associated #0: 35 / 0.833 ->
en:aceclidine hydrochloride
n1=en:pralidoxime mesylate | n2=en:aceclidine hydrochloride | rel=r_associated | relid=0 | w=35
- en:pralidoxime mesylate --
r_associated #0: 35 / 0.833 ->
en:alvameline maleate
n1=en:pralidoxime mesylate | n2=en:alvameline maleate | rel=r_associated | relid=0 | w=35
- en:pralidoxime mesylate --
r_associated #0: 35 / 0.833 ->
en:benzpyrinium
n1=en:pralidoxime mesylate | n2=en:benzpyrinium | rel=r_associated | relid=0 | w=35
- en:pralidoxime mesylate --
r_associated #0: 35 / 0.833 ->
en:pralidoxime mesylate 200mg/ml injection solution 5ml ampule
n1=en:pralidoxime mesylate | n2=en:pralidoxime mesylate 200mg/ml injection solution 5ml ampule | rel=r_associated | relid=0 | w=35
- en:pralidoxime mesylate --
r_associated #0: 34 / 0.81 ->
en:itameline
n1=en:pralidoxime mesylate | n2=en:itameline | rel=r_associated | relid=0 | w=34
- en:pralidoxime mesylate --
r_associated #0: 34 / 0.81 ->
en:muscarinic agonists
n1=en:pralidoxime mesylate | n2=en:muscarinic agonists | rel=r_associated | relid=0 | w=34
- en:pralidoxime mesylate --
r_associated #0: 32 / 0.762 ->
en:aclatonium
n1=en:pralidoxime mesylate | n2=en:aclatonium | rel=r_associated | relid=0 | w=32
- en:pralidoxime mesylate --
r_associated #0: 32 / 0.762 ->
en:carpronium
n1=en:pralidoxime mesylate | n2=en:carpronium | rel=r_associated | relid=0 | w=32
- en:pralidoxime mesylate --
r_associated #0: 32 / 0.762 ->
en:furtrethonium iodide
n1=en:pralidoxime mesylate | n2=en:furtrethonium iodide | rel=r_associated | relid=0 | w=32
- en:pralidoxime mesylate --
r_associated #0: 32 / 0.762 ->
en:pilocarpine nitrate
n1=en:pralidoxime mesylate | n2=en:pilocarpine nitrate | rel=r_associated | relid=0 | w=32
- en:pralidoxime mesylate --
r_associated #0: 32 / 0.762 ->
en:pralidoxime
n1=en:pralidoxime mesylate | n2=en:pralidoxime | rel=r_associated | relid=0 | w=32
- en:pralidoxime mesylate --
r_associated #0: 31 / 0.738 ->
en:atropine+pralidoxime
n1=en:pralidoxime mesylate | n2=en:atropine+pralidoxime | rel=r_associated | relid=0 | w=31
- en:pralidoxime mesylate --
r_associated #0: 31 / 0.738 ->
en:dichlorphenamide
n1=en:pralidoxime mesylate | n2=en:dichlorphenamide | rel=r_associated | relid=0 | w=31
- en:pralidoxime mesylate --
r_associated #0: 31 / 0.738 ->
en:milameline hydrochloride
n1=en:pralidoxime mesylate | n2=en:milameline hydrochloride | rel=r_associated | relid=0 | w=31
- en:pralidoxime mesylate --
r_associated #0: 31 / 0.738 ->
en:pilocarpine hydrochloride
n1=en:pralidoxime mesylate | n2=en:pilocarpine hydrochloride | rel=r_associated | relid=0 | w=31
- en:pralidoxime mesylate --
r_associated #0: 31 / 0.738 ->
en:vinconate
n1=en:pralidoxime mesylate | n2=en:vinconate | rel=r_associated | relid=0 | w=31
- en:pralidoxime mesylate --
r_associated #0: 30 / 0.714 ->
en:aceclidine
n1=en:pralidoxime mesylate | n2=en:aceclidine | rel=r_associated | relid=0 | w=30
- en:pralidoxime mesylate --
r_associated #0: 30 / 0.714 ->
en:alvameline
n1=en:pralidoxime mesylate | n2=en:alvameline | rel=r_associated | relid=0 | w=30
- en:pralidoxime mesylate --
r_associated #0: 30 / 0.714 ->
en:arecoline
n1=en:pralidoxime mesylate | n2=en:arecoline | rel=r_associated | relid=0 | w=30
- en:pralidoxime mesylate --
r_associated #0: 30 / 0.714 ->
en:cevimeline hydrochloride
n1=en:pralidoxime mesylate | n2=en:cevimeline hydrochloride | rel=r_associated | relid=0 | w=30
- en:pralidoxime mesylate --
r_associated #0: 30 / 0.714 ->
en:nicotinic agonist
n1=en:pralidoxime mesylate | n2=en:nicotinic agonist | rel=r_associated | relid=0 | w=30
- en:pralidoxime mesylate --
r_associated #0: 29 / 0.69 ->
en:acetylcholine
n1=en:pralidoxime mesylate | n2=en:acetylcholine | rel=r_associated | relid=0 | w=29
- en:pralidoxime mesylate --
r_associated #0: 29 / 0.69 ->
en:benzpyrinium bromide
n1=en:pralidoxime mesylate | n2=en:benzpyrinium bromide | rel=r_associated | relid=0 | w=29
- en:pralidoxime mesylate --
r_associated #0: 29 / 0.69 ->
en:pralidoxime chloride 1g/20ml powder for injection 20ml vial
n1=en:pralidoxime mesylate | n2=en:pralidoxime chloride 1g/20ml powder for injection 20ml vial | rel=r_associated | relid=0 | w=29
- en:pralidoxime mesylate --
r_associated #0: 29 / 0.69 ->
en:pralidoxime iodide
n1=en:pralidoxime mesylate | n2=en:pralidoxime iodide | rel=r_associated | relid=0 | w=29
- en:pralidoxime mesylate --
r_associated #0: 29 / 0.69 ->
en:tilorone hydrochloride
n1=en:pralidoxime mesylate | n2=en:tilorone hydrochloride | rel=r_associated | relid=0 | w=29
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:aclatonium napadisilate
n1=en:pralidoxime mesylate | n2=en:aclatonium napadisilate | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:carpronium chloride
n1=en:pralidoxime mesylate | n2=en:carpronium chloride | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:echothiophate
n1=en:pralidoxime mesylate | n2=en:echothiophate | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:pralidoxime chloride
n1=en:pralidoxime mesylate | n2=en:pralidoxime chloride | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:tazomeline citrate
n1=en:pralidoxime mesylate | n2=en:tazomeline citrate | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 28 / 0.667 ->
en:tiametonium iodide
n1=en:pralidoxime mesylate | n2=en:tiametonium iodide | rel=r_associated | relid=0 | w=28
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:arecoline hydrobromide
n1=en:pralidoxime mesylate | n2=en:arecoline hydrobromide | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:fda established names and unique ingredient identifier codes terminology
n1=en:pralidoxime mesylate | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:muscarinic agonist apd515
n1=en:pralidoxime mesylate | n2=en:muscarinic agonist apd515 | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:pilocarpine
n1=en:pralidoxime mesylate | n2=en:pilocarpine | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:talsaclidine
n1=en:pralidoxime mesylate | n2=en:talsaclidine | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:tazomeline
n1=en:pralidoxime mesylate | n2=en:tazomeline | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 27 / 0.643 ->
en:tenocyclidine
n1=en:pralidoxime mesylate | n2=en:tenocyclidine | rel=r_associated | relid=0 | w=27
- en:pralidoxime mesylate --
r_associated #0: 26 / 0.619 ->
en:aceclidine salicylate
n1=en:pralidoxime mesylate | n2=en:aceclidine salicylate | rel=r_associated | relid=0 | w=26
- en:pralidoxime mesylate --
r_associated #0: 26 / 0.619 ->
en:acetylcholine chloride
n1=en:pralidoxime mesylate | n2=en:acetylcholine chloride | rel=r_associated | relid=0 | w=26
- en:pralidoxime mesylate --
r_associated #0: 26 / 0.619 ->
en:cevimeline
n1=en:pralidoxime mesylate | n2=en:cevimeline | rel=r_associated | relid=0 | w=26
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:duodote
n1=en:pralidoxime mesylate | n2=en:duodote | rel=r_associated | relid=0 | w=20
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:milameline
n1=en:pralidoxime mesylate | n2=en:milameline | rel=r_associated | relid=0 | w=20
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:n-methylpyridinium 2-aldoxime methylsulfate
n1=en:pralidoxime mesylate | n2=en:n-methylpyridinium 2-aldoxime methylsulfate | rel=r_associated | relid=0 | w=20
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:parietaria officinalis extract
n1=en:pralidoxime mesylate | n2=en:parietaria officinalis extract | rel=r_associated | relid=0 | w=20
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:paroxetine hydrochloride anhydrous
n1=en:pralidoxime mesylate | n2=en:paroxetine hydrochloride anhydrous | rel=r_associated | relid=0 | w=20
- en:pralidoxime mesylate --
r_associated #0: 20 / 0.476 ->
en:peg-12 laurate
n1=en:pralidoxime mesylate | n2=en:peg-12 laurate | rel=r_associated | relid=0 | w=20
| ≈ 54 relations entrantes
- en:pralidoxime chloride 1g/20ml powder for injection 20ml vial ---
r_associated #0: 43 -->
en:pralidoxime mesylate
n1=en:pralidoxime chloride 1g/20ml powder for injection 20ml vial | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=43
- en:pralidoxime mesylate 200mg/ml injection solution 5ml ampule ---
r_associated #0: 41 -->
en:pralidoxime mesylate
n1=en:pralidoxime mesylate 200mg/ml injection solution 5ml ampule | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=41
- en:arecoline ---
r_associated #0: 35 -->
en:pralidoxime mesylate
n1=en:arecoline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=35
- en:n-methylpyridinium 2-aldoxime methylsulfate ---
r_associated #0: 34 -->
en:pralidoxime mesylate
n1=en:n-methylpyridinium 2-aldoxime methylsulfate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=34
- en:paroxetine hydrochloride anhydrous ---
r_associated #0: 34 -->
en:pralidoxime mesylate
n1=en:paroxetine hydrochloride anhydrous | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=34
- en:tenocyclidine ---
r_associated #0: 34 -->
en:pralidoxime mesylate
n1=en:tenocyclidine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=34
- en:fda established names and unique ingredient identifier codes terminology ---
r_associated #0: 32 -->
en:pralidoxime mesylate
n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=32
- en:atropine+pralidoxime ---
r_associated #0: 31 -->
en:pralidoxime mesylate
n1=en:atropine+pralidoxime | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=31
- en:pralidoxime chloride ---
r_associated #0: 31 -->
en:pralidoxime mesylate
n1=en:pralidoxime chloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=31
- en:carpronium chloride ---
r_associated #0: 30 -->
en:pralidoxime mesylate
n1=en:carpronium chloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=30
- en:parietaria officinalis extract ---
r_associated #0: 30 -->
en:pralidoxime mesylate
n1=en:parietaria officinalis extract | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=30
- en:tazomeline ---
r_associated #0: 30 -->
en:pralidoxime mesylate
n1=en:tazomeline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=30
- en:duodote ---
r_associated #0: 29 -->
en:pralidoxime mesylate
n1=en:duodote | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=29
- en:milameline ---
r_associated #0: 29 -->
en:pralidoxime mesylate
n1=en:milameline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=29
- en:peg-12 laurate ---
r_associated #0: 29 -->
en:pralidoxime mesylate
n1=en:peg-12 laurate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=29
- en:aceclidine ---
r_associated #0: 28 -->
en:pralidoxime mesylate
n1=en:aceclidine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=28
- en:dichlorphenamide ---
r_associated #0: 28 -->
en:pralidoxime mesylate
n1=en:dichlorphenamide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=28
- en:aclatonium napadisilate ---
r_associated #0: 27 -->
en:pralidoxime mesylate
n1=en:aclatonium napadisilate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=27
- en:itameline ---
r_associated #0: 27 -->
en:pralidoxime mesylate
n1=en:itameline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=27
- en:nicotinic agonist ---
r_associated #0: 27 -->
en:pralidoxime mesylate
n1=en:nicotinic agonist | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=27
- en:tilorone hydrochloride ---
r_associated #0: 27 -->
en:pralidoxime mesylate
n1=en:tilorone hydrochloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=27
- en:vinconate ---
r_associated #0: 26 -->
en:pralidoxime mesylate
n1=en:vinconate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=26
- en:aceclidine hydrochloride ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:aceclidine hydrochloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:aceclidine salicylate ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:aceclidine salicylate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:acetylcholine ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:acetylcholine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:acetylcholine chloride ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:acetylcholine chloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:aclatonium ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:aclatonium | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:alvameline ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:alvameline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:alvameline maleate ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:alvameline maleate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:arecoline hydrobromide ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:arecoline hydrobromide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:benzpyrinium ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:benzpyrinium | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:benzpyrinium bromide ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:benzpyrinium bromide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:carpronium ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:carpronium | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:cevimeline ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:cevimeline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:cevimeline hydrochloride ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:cevimeline hydrochloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:echothiophate ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:echothiophate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:furtrethonium iodide ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:furtrethonium iodide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:milameline hydrochloride ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:milameline hydrochloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:muscarinic agonist apd515 ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:muscarinic agonist apd515 | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:muscarinic agonists ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:muscarinic agonists | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:pilocarpine ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:pilocarpine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:pilocarpine hydrochloride ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:pilocarpine hydrochloride | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:pilocarpine nitrate ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:pilocarpine nitrate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:pralidoxime ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:pralidoxime | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:pralidoxime iodide ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:pralidoxime iodide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:talsaclidine ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:talsaclidine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:tazomeline citrate ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:tazomeline citrate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:tiametonium iodide ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:tiametonium iodide | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- en:vedaclidine ---
r_associated #0: 20 -->
en:pralidoxime mesylate
n1=en:vedaclidine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=20
- acetylcholine ---
r_associated #0: 15 -->
en:pralidoxime mesylate
n1=acetylcholine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=15
- pilocarpine ---
r_associated #0: 10 -->
en:pralidoxime mesylate
n1=pilocarpine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=10
- échothiophate ---
r_associated #0: 10 -->
en:pralidoxime mesylate
n1=échothiophate | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=10
- acétyl-choline ---
r_associated #0: 5 -->
en:pralidoxime mesylate
n1=acétyl-choline | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=5
- acétylcholine ---
r_associated #0: 5 -->
en:pralidoxime mesylate
n1=acétylcholine | n2=en:pralidoxime mesylate | rel=r_associated | relid=0 | w=5
|